Showing results (281-290 of 378) with videos related to
Sort By:
Pageof 38
Journal of Cancer Research and Therapeutics|May 19, 2010
18 F-FDG avid lesion due to coexistent fibrous dysplasia in a child of embryonal rhabdomyosarcoma: source of false positive FDG-PETSandip Basu, N S Baghel, Ajay Puri, et al.Frontiers in Bioscience (Elite Edition)|December 29, 2011
Functional oncoimaging techniques with potential clinical applicationsThomas C Kwee, Sandip Basu, Babak Saboury, et al.Journal of Nuclear Medicine Technology|June 9, 2026
Pictorial Essay of [18F]FDG PET/CT in the Evaluation of Suspected Infection of Cardiac Devices and Infective Endocarditis: Patient Preparation, Pathophysiologic Findings, and InterpretationAustin Saju, Sunita Sonavane, Keyur Rajendra Rathod, et al.Nuclear Medicine Communications|April 10, 2026
Pilot feasibility study investigating 68Ga-NODAGA-RGD PET-computed tomography molecular angiogenesis imaging in patients with peripheral arterial diseases: can it be of potential clinical value?Vishwajeet Jadhav, Priyanka Verma, Ashok Chandak, et al.Nuclear Medicine Communications|May 7, 2008
Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PETArnold Berkowitz, Sandip Basu, Shyam Srinivas, et al.Clinical Nuclear Medicine|August 18, 2012
Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up dataGulin Ucmak Vural, Burcu Esen Akkas, Nur Ercakmak, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2011
Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this settingThomas C Kwee, Sandip Basu, Drew A Torigian, et al.Endocrine|March 25, 2025
Evaluating the prognostic significance of the pre-treatment neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios in 177Lu-DOTATATE PRRT treated patients with advanced metastatic neuroendocrine tumorsMahesh K Padwal, Amir K Nazar, Rahul V Parghane, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 29, 2015
Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal MetastasesPradeep Thapa, Dilip Nikam, Tapas Das, et al.Nuclear Medicine Communications|January 2, 2024
Normal physiological distribution and tumor localization of 64 CuCl 2 in different human malignancies along with semiquantitative scoring: a comparative evaluation with 18 Fluorodeoxyglucose ( 18 FDG) PET-CTParth Baberwal, Sunita Sonavane, K V Vimalnath, et al.Pageof 38